DE602004022645D1 - Beurteilung von nervenschäden anhand von blutproben - Google Patents

Beurteilung von nervenschäden anhand von blutproben

Info

Publication number
DE602004022645D1
DE602004022645D1 DE602004022645T DE602004022645T DE602004022645D1 DE 602004022645 D1 DE602004022645 D1 DE 602004022645D1 DE 602004022645 T DE602004022645 T DE 602004022645T DE 602004022645 T DE602004022645 T DE 602004022645T DE 602004022645 D1 DE602004022645 D1 DE 602004022645D1
Authority
DE
Germany
Prior art keywords
evaluation
blood samples
damage due
nerve damage
detected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004022645T
Other languages
English (en)
Inventor
Gerry Shaw
Brian R Pike
Sonal S Tuli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
University of Florida Research Foundation Inc
Original Assignee
University of Florida
University of Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida, University of Florida Research Foundation Inc filed Critical University of Florida
Publication of DE602004022645D1 publication Critical patent/DE602004022645D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE602004022645T 2003-03-31 2004-03-26 Beurteilung von nervenschäden anhand von blutproben Expired - Lifetime DE602004022645D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45928603P 2003-03-31 2003-03-31
PCT/US2004/009114 WO2004091379A2 (en) 2003-03-31 2004-03-26 Assessing neuronal damage from blood samples

Publications (1)

Publication Number Publication Date
DE602004022645D1 true DE602004022645D1 (de) 2009-10-01

Family

ID=33299668

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004022645T Expired - Lifetime DE602004022645D1 (de) 2003-03-31 2004-03-26 Beurteilung von nervenschäden anhand von blutproben

Country Status (11)

Country Link
US (3) US20040241762A1 (de)
EP (1) EP1613204B1 (de)
JP (1) JP4557971B2 (de)
AT (1) ATE440286T1 (de)
AU (1) AU2004229317B2 (de)
CA (1) CA2520945C (de)
DE (1) DE602004022645D1 (de)
DK (1) DK1613204T3 (de)
ES (1) ES2332136T3 (de)
HK (1) HK1085538A1 (de)
WO (1) WO2004091379A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005245785B2 (en) * 2004-04-15 2011-04-07 Banyan Biomarkers Inc. Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
WO2007139866A2 (en) * 2006-05-24 2007-12-06 The University Of Miami Screening method and system to estimate the severity of injury in critically ill patients
EP2124056A4 (de) * 2006-12-27 2010-06-02 Japan Science & Tech Agency Immunologisches nachweisverfahren unter verwendung von vogelantikörper
WO2012005588A2 (en) * 2010-07-07 2012-01-12 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Novel biomarkers for detecting neuronal loss
CN106461645A (zh) * 2014-04-07 2017-02-22 铁马诊断公司 外伤性脑损伤和神经退行性生物标记物、方法和系统
WO2020023899A1 (en) * 2018-07-27 2020-01-30 Veravas, Inc. Methods for depletion and enrichment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86652A1 (de) * 1986-11-10 1988-06-13 Progen Biotechnik Gmbh Verfahren zum auffinden von gewebslaesionen
ATE145285T1 (de) * 1988-12-21 1996-11-15 Gen Hospital Corp Nachweis einer neurologischen krankheit oder einer funktionsstörung
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
GB9719879D0 (en) * 1997-09-19 1997-11-19 Neuropa Ltd Protein
US6589746B1 (en) * 1999-10-21 2003-07-08 University Of Cincinnati Method of detecting axonally-derived protein tau in patients with traumatic CNS injury

Also Published As

Publication number Publication date
ES2332136T3 (es) 2010-01-27
US20160349272A1 (en) 2016-12-01
CA2520945C (en) 2014-03-25
US20100184105A1 (en) 2010-07-22
CA2520945A1 (en) 2004-10-28
EP1613204A2 (de) 2006-01-11
JP4557971B2 (ja) 2010-10-06
HK1085538A1 (en) 2006-08-25
AU2004229317B2 (en) 2012-01-12
DK1613204T3 (da) 2009-12-07
AU2004229317A1 (en) 2004-10-28
JP2006522336A (ja) 2006-09-28
ATE440286T1 (de) 2009-09-15
WO2004091379A3 (en) 2005-12-22
EP1613204A4 (de) 2007-04-04
US20040241762A1 (en) 2004-12-02
WO2004091379A2 (en) 2004-10-28
EP1613204B1 (de) 2009-08-19

Similar Documents

Publication Publication Date Title
TW200643400A (en) Optical-based sensing devices
ATE520974T1 (de) Raman-spektralanalyse von unter der oberfläche liegenden geweben und flüssigkeiten
WO2008108792A3 (en) An integrated airborne substance collection and detection system
ATE482744T1 (de) Vorrichtung zur erkennung und behandlung von depressionen
DE602004001227D1 (de) Nukleinsäure-biosensor
WO2013152087A3 (en) Sweat simulation, collection and sensing systems
BRPI0606807A2 (pt) dispositivo para analisar partìculas em uma amostra e método para analisar partìculas em uma amostra que contém as referidas partìculas
DE602004024322D1 (de) Vorrichtung zur Detektion von Computerbenutzern
EP2472425A3 (de) System und Verfahren zur Erkennung einer unbekannten Malware
TW200801503A (en) Underfill detection system for a biosensor
EA200500355A1 (ru) Способ обнаружения, характеристики и мониторинга углеводородных месторождений
EP1415152A4 (de) Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde
HK1079571A1 (en) Methods for direct detection of individual methotrexate metabolites
ATE498134T1 (de) Nachweis von staphylococcus
HK1085538A1 (en) Assessing neuronal damage from blood samples
DE60324925D1 (de) Ace2-aktivierung zur behandlung von herz, lungen, und nierenkrankheit und bluthochdruck
ATE459289T1 (de) Katheter zur abnahme von blut
BRPI0620212B8 (pt) método de discriminação e de contagem de pelo menos duas populações de elementos biológicos portadoras de características específicas, e, utilização do método
CY1112090T1 (el) Μεθοδος για ανιχνευση βιολογικων οργανισμων με χρηση σκεδασης raman
DK2038430T3 (da) Toll-Like-Receptor-4-dysfunktion og de biologiske anvendelser deraf
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
WO2004057341A3 (en) Cvd assay
WO2014100150A8 (en) Device and methods for detection of analytes including use of a colorimetric barcode
EP2211176A3 (de) Analyse von Nervenzellenbeschädigungen
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: ELBEL, M., DIPL.-BIOL.UNIV. DR.RER.NAT., PAT.-ANW.